Market Share of Scleroderma Therapeutics Industry
The scleroderma therapeutics market is moderately consolidated due to the presence of a few companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well-known. These companies are Boehringer Ingelheim International GmbH, Celgene Corporation, Johnson & Johnson Services, Inc., Prometic Life Sciences Inc., Kadmon Holdings Inc., Emerald Health Pharmaceuticals, Cytori Therapeutics Inc., Bayer AG, F. Hoffman La Roche Ltd, arGentis Pharmaceuticals LLC, GlaxoSmithKline PLC, and Novartis AG.
Scleroderma Therapeutics Market Leaders
Boehringer Ingelheim International GmbH
Celgene Corporation
arGentis Pharmaceuticals Llc
Kadmon Holdings, Inc.
Emerald Health Pharmaceuticals
*Disclaimer: Major Players sorted in no particular order
